The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 7 of the 28 sources its claims cite were checked for support.
Abstract
Global prospects for COVID-19 control: Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the potentially protective effects of younger demographics, the closer intergenerational contact, limitations on health care facilities, and frequency of comorbidities in lower-income countries require sustained nonpharmaceutical interventions (NPIs) to avoid overwhelming health care capacity. As a result of strict NPIs, the protective effects of immunity will be reduced, and it will be important to improve testing capacity. Ensuring equitable provision of oxygen and—when they are ready—pharmaceutical interventions should be a global priority. Science , this issue p. 413 ; see also p. 368
Overview
CoChat Summary
TL;DR
Walker et al. model COVID-19 in low- and middle-income countries using demographic, contact, and health-system data, finding that younger populations reduce per-capita risk but limited health care capacity and quality can offset this advantage. They conclude sustained nonpharmaceutical interventions, especially suppression, are needed to avoid overwhelming health systems, with major testing and oxygen gaps.
Key findings
- In an unmitigated epidemic with R0 = 3.0, attack rates are similar across settings, slightly higher in LICs due to more homogeneous age mixing; assuming the same comorbidity profile and China-level care, lower-income settings have lower per-capita hospitalization, critical care, and mortality because of younger demography.
- Health care capacity is strongly income-graded: LICs have a median 1.28 hospital beds per 1000 population versus 4.68 in HICs; ICU beds are 1.47% of hospital beds in LICs versus 3.30% in HICs. Under mitigation, peak critical care demand exceeds supply by a factor of 30.7 (95% UI 14.7–48.8) in a typical LIC versus 7.8 (95% UI 3.6–13.0) in a typical HIC; LMICs and UMICs show factors of 17.5 and 10.9, respectively.
- Under mitigation, modeled deaths per 1000 population in LICs are 2.1 (95% UI 1.0–3.3) with unlimited HIC-quality care, 4.6 (95% UI 1.4–10.0) with capacity limits, and 6.5 (95% UI 2.7–12.3) with poorer-quality care; in LMICs the corresponding estimates are 2.4 (1.1–3.9), 3.9 (1.5–8.9), and 6.2 (2.8–11.9). Excess deaths due to poorer quality and lack of capacity are 4.4 (1.7–9.0) and 3.8 (1.7–8.0) per 1000 in LICs and LMICs, respectively.
- For R0 = 3.0, optimal mitigation reduces infections by 30–38% (median 33%) and mortality by 19–55% (median 39%); adding enhanced social distancing of elderly individuals raises mortality reduction to 23–67% (median 49%). Proportional mortality reductions are lower in LICs (median 25.3% vs 49.9% in HICs for optimized mitigation including social distancing; 32.6% vs 60.1% with elderly-enhanced distancing). Suppression with a 75% contact reduction gives Rt = 0.75 for R0 = 3.0; to keep ICU demand below capacity, LICs are predicted to spend 77% of an 18-month period in suppression versus 66% in HICs. Prior to suppression, median reported cases per death were 8.6 in LICs, 19.3 in LMICs, and 72.6 in HICs.
Methods
- Collated global demographic projections by age and country and social mixing data by age and country-level income; used a simple SIR model to estimate final attack rates and applied age-specific hospitalization, critical care, and infection fatality ratio estimates, with central R0 = 3.0 (range 2.3–3.5).
- Modeled health care supply using a boosted regression tree with World Bank covariates to predict hospital beds per 1000 population, combined with ICU beds per 100 hospital beds from a systematic review; integrated expert clinical opinion on COVID-19 outcomes under scenarios of unlimited, limited, and limited/no mechanical ventilation/poorer-quality care.
- Used an age-structured SEIR model to explore mitigation (Rt > 1) and suppression (Rt < 1) under health-system capacity constraints, generating 500 parameter sets with 10 stochastic realizations each; reviewed the ACAP COVID-19 Government Response Measures dataset to summarize when countries implemented suppression measures.
Limitations
- Stated: the paper cannot predict exact cases, mortality, or disease burden for any country, and full understanding will only be available retrospectively; it does not quantify wider societal and economic impacts, nor does it address the challenge of intensive suppression in LICs/LMICs where informal labor limits adherence.
- Stated: durable immunity to reinfection remains uncertain; all symptomatic cases are assumed to seek care; hospital stay durations are based on UK data and likely shorter in LIC/LMIC settings, making results conservative; HIC ICU capacity estimates are drawn almost exclusively from a review of Asian countries and may not reflect HICs worldwide; health care quality estimates rely on expert clinical opinion with likely heterogeneity not captured.
- Evident: the model does not specify the combinations of NPIs needed to achieve contact reductions, and it does not include pharmaceutical interventions except through an assumed 18-month time window; income-stratified representative settings and contact surveys may not capture within-country heterogeneity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
4 Valid · 1 Not valid · 16 Not checked · 64 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, this single peak relies upon the assumption that recovery from infection confers durable immunity to reinfection, which has yet to be conclusively demonstrated (16).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Mitigation and suppression strategies for low- and middle-income countries
What the sources say
- Supportedcites [16] Altmann D. M., Douek D. C., Boyton R. J., What policy makers need to know about COVID-19 protective immunity. Lancet 395, 1527– 1529 (2020). 10.1016/S0140-6736(20)30985-5 32353328 PMC7185915 source
Our copy of Altmann et al. states directly that protection after recovery is unresolved: reinfection reports from China and South Korea are 'anecdotal' and 'should be regarded with caution' because PCR-negative 'recovered' individuals might have harboured persistent virus, with virus sequencing still needed to resolve the issue (reinfection passage). It also says 'There is no certainty as to the immunological correlates of antiviral protection or the proportion of the population who must attain them, making it impossible to identify a point when this level of immunity has been reached' (lockdown-exit passage), and on duration that the best estimate from related coronaviruses is that immunity 'might wane', with studies of just over 1 year 'of little reassurance' given possible waves in 3–4 years ('How long is immunity to COVID-19 likely to last?'). The 'single peak under optimal mitigation' framing is the citing paper's own model and is not attributed to this source; the clause the citation supports — that durable immunity to reinfection after recovery has yet to be conclusively demonstrated — is stated in our copy. (LLM, conf=0.85)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The experience in countries to date has emphasized the intense pressure that a COVID-19 epidemic places on national health systems, with demand for intensive care beds and mechanical ventilators rapidly outstripping their availability, even in relatively highly resourced settings (2).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Abstract
What the sources say
- Partly supportedcites [2] Remuzzi A., Remuzzi G., COVID-19 and Italy: What next? Lancet 395, 1225– 1228 (2020). 10.1016/S0140-6736(20)30627-9 32178769 PMC7102589 sourceExperimental — accuracy not yet measured
The Modelling predictions section forecasts that Italy’s intensive-care capacity would be reached within days, and the Conclusion describes enormous pressure in Lombardy and an urgent plan to provide 5,000 more ventilators. The paper supports the pressure on a relatively well-resourced health system, but it presents demand exceeding capacity chiefly as a prediction, not an established outcome across countries; it also does not establish that ventilator demand had already outstripped availability. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, as has been observed, HICs and UMICs are likely to be able to put in place surge capacity to limit any impact on mortality (19–21).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Mitigation and suppression strategies for low- and middle-income countries
What the sources say
- Partly supportedcites [19] Carenzo L., Costantini E., Greco M., Barra F. L., Rendiniello V., Mainetti M., Bui R., Zanella A., Grasselli G., Lagioia M., Protti A., Cecconi M., Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia 75, 928– 934 (2020). 10.1111/anae.15072 32246838 sourceExperimental — accuracy not yet measured
The Critical care area operations section (page unavailable) describes a Milan hospital expanding its ICU and ward capacity during the outbreak. It does not assess whether HICs and UMICs generally can do so, or whether surge capacity limits mortality. (LLM, conf=0.86)
- Partly supportedcites [20] A. Zangrillo et al, Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency. Crit. Care Resusc. (2020); www.ncbi.nlm.nih.gov/pubmed/32227819. PMC10692483 32227819 sourceExperimental — accuracy not yet measured
The ‘Increasing intensive care unit and general ward capacity’ section (page not provided) documents a Milan hospital’s rapid expansion of ICU capacity to 72 beds. It does not assess whether HICs and UMICs generally can do so or whether surge capacity limits mortality. (LLM, conf=0.86)
- Not checked yetcites [21] Litton E., Bucci T., Chavan S., Ho Y. Y., Holley A., Howard G., Huckson S., Kwong P., Millar J., Nguyen N., Secombe P., Ziegenfuss M., Pilcher D., Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia. Med. J. Aust. 212, 463– 467 (2020). 10.5694/mja2.50596 32306408 PMC7264562 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Once the number of new infections drops to a manageable level, it is likely that more widespread testing and isolation of cases coupled with contact tracing can help to prevent a resurgence of transmission, as has been observed in countries such as South Korea (26–28).”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Suppression and longer-term exit strategies
What the sources say
- Not checked yetcites [26] Consulate General of the Republic of Korea, “Flattening the curve on COVID-19 - How Korea responded to a pandemic using ICT” (2020); http://overseas.mofa.go.kr/us-houston-en/brd/m_5573/view.do?seq=759765.
- Partly supportedcites [27] COVID-19 National Emergency Response Center, Epidemiology & Case Management Team, Korea Centers for Disease Control & Prevention, Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts. Osong Public Health Res. Perspect. 11, 60–63 (2020). PMC7045882 32149043 sourceExperimental — accuracy not yet measured
The Introduction describes contact management as a strategy to minimize additional transmission, and the Results describe tracing contacts and using quarantine or isolation in South Korea (pages not provided). The paper does not address more widespread testing, a threshold at which new infections become manageable, or an observed prevention of resurgence; the Discussion says the effectiveness of its monitoring methods still needs evaluation. (LLM, conf=0.87)
- Could not verifycites [28] Ainslie K. E. C., Walters C. E., Fu H., Bhatia S., Wang H., Xi X., Baguelin M., Bhatt S., Boonyasiri A., Boyd O., Cattarino L., Ciavarella C., Cucunuba Z., Cuomo-Dannenburg G., Dighe A., Dorigatti I., van Elsland S. L., FitzJohn R., Gaythorpe K., Ghani A. C., Green W., Hamlet A., Hinsley W., Imai N., Jorgensen D., Knock E., Laydon D., Nedjati-Gilani G., Okell L. C., Siveroni I., Thompson H. A., Unwin H. J. T., Verity R., Vollmer M., Walker P. G. T., Wang Y., Watson O. J., Whittaker C., Winskill P., Donnelly C. A., Ferguson N. M., Riley S., Evidence of initial success for China exiting COVID-19 sourceExperimental — accuracy not yet measured
The Introduction and Discussion describe containment in China and the relationship between movement and transmission. The Methods mention testing to define reported cases, but no passage addresses whether testing, isolation and contact tracing prevent resurgence or reports that outcome in South Korea. Searches for South Korea and for testing, isolation and contact tracing found no supporting passage. (LLM, conf=0.74)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“suppression will always have the greatest impact on COVID-related morbidity and mortality”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Conclusions
What the sources say
- Not checked yetcites [31] A. B. Hogan, B. Jewell, E. Sherrard-Smith, J. Vesga, O. J. Watson, C. Whittaker, et al., Report 19: The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low-and Middle-Income Countries; 10.25561/78670. 10.25561/78670
- Could not verifycites [32] Korenromp E. L., Lives saved from malaria prevention in Africa—Evidence to sustain cost-effective gains. Malar. J. 11, 94 (2012). 10.1186/1475-2875-11-94 22455309 PMC3373378 sourceExperimental — accuracy not yet measured
Our copy of Korenromp (2012) is entirely about malaria-prevention impact estimates with the Lives Saved Tool (ITN/LLIN coverage, ACT case management, IRS) in sub-Saharan Africa; no passage addresses SARS-CoV-2/COVID-19 or a 'suppression' strategy's relative impact on morbidity and mortality. Searches for 'suppression ... greatest impact on morbidity and mortality' and for 'coronavirus / influenza / pandemic / transmission reduction' returned only the Discussion (pp. on mortality measurement, dynamic transmission modelling, and the 2000 counterfactual) and reference-list entries. Since the paper neither states nor contradicts the claim, the attribution cannot be checked against this source. (LLM, conf=0.78)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
47 more claims
Create a free account to see all 85 claims and to verify the 20 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 7
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This variation can be explained by a combination of factors including policies enacted by governments to encourage mask use and reduce social interaction,48, 49, 50 presence of escape variants, testing and contact tracing capacity,51, 52 previous exposure to other coronaviruses,53 baseline patterns of social interaction, and more.”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredIn the citing paper
“The effect of COVID-19 on healthcare infrastructure in LMICs, however, is arguably more extreme due to the health system capacity and deeper dependency on families for support of PwD (Walker et al., 2020).”
From Robotic Telemedicine for Mental Health: A Multimodal Approach to Improve Human-Robot Engagement (2021) · cites this paper as Walker et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Worldwide | 121 | 24/03 (08/03–19/04) | 6.01 (0–449.24) | 0 (0–10.447) | 50 | 45.8 (5.1–325.2) |”
§ The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries > Suppression and longer-term exit strategies
Reported 50 · recomputed 49
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Self-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationLauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., Webster, S., Cameron-Blake, E., Hallas, L., Majumdar, S., et al. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01079-8 · Cited by 4,578
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Self-citationHow will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,281
Self-citation
Cited by
Items 701–800 of 991
Tweneboah-Koduah, D. (2025) · African Quarterly Social Science Review · doi:10.51867/aqssr.2.3.12 · Cited by 1
Simayi, T., & Tatira, B. (2025) · Edelweiss Applied Science and Technology · doi:10.55214/2576-8484.v9i8.9691 · Cited by 1
Community pharmacy resiliency during Covid-19 pandemic in Iran: A qualitative study
Zomorodi, Z., Sharif, F. V., Moradi, N., & Sharif, Z. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100670 · Cited by 1
Behavior Analysis of Pandemic Source Media Communications
Bautista, Y. J. P., Liu, J., & Aló, R. (2021) · IEEE International Conference on Big Data and Smart Computing (BigComp) · doi:10.1109/bigcomp51126.2021.00018 · Cited by 1
Zhong, S., Chen, Z., Wang, Y., Sheng, P., Shi, S., Lyu, Y., Bai, R., Wang, P., Dong, J., Ba, J., et al. (2021) · China CDC Weekly · doi:10.46234/ccdcw2021.195 · Cited by 1
Self-citationFinancing for a Resilient Health System in India: Lessons from the COVID Pandemic
Gupta, I. (2022) · Springer eBooks · doi:10.1007/978-981-16-7385-6_13 · Cited by 1
Incidence, survival and mortality for colorectal cancer
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/3604edf9-en · Cited by 1
Modeling the influence of vaccine passport on the outbreak of epidemic with asymptomatic infection
Chen, Y., Zhou, L., & Chu, H. (2022) · International Journal of Modern Physics C · doi:10.1142/s012918312350064x · Cited by 1
Flagship Projects for Accelerating R&D During the COVID-19 Period in Kuwait
Omar, S. A. S., & AlMomin, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-07539-1_17 · Cited by 1
Namnabati, M., Sotoudeh, R., & Bahrami, N. (2023) · Home Health Care Management & Practice · doi:10.1177/10848223231157045 · Cited by 1
Adeloye, K. A., Torimiro, D. O., & Olufemi, D. S. (2023) · Agropecuária Catarinense · doi:10.52945/rac.v36i1.1523 · Cited by 1
The offices of the U.S. president as policy tools
Pepin‐Neff, C. L., McManus, W., & Ormerod, B. (2023) · Cogent Social Sciences · doi:10.1080/23311886.2023.2225335 · Cited by 1
Impact of COVID-19 pandemic in dermatology outpatient visits
Fida, M., Toçi, D., Toçi, E., Dedej, S., Tafica, A., Kore, A., & Vasili, E. (2023) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v12i3.22595 · Cited by 1
Tropical forest environments provide insurance against COVID-19
Takasaki, Y., Coomes, O. T., & Abizaid, C. (2023) · Ecology and Society · doi:10.5751/es-14349-280308 · Cited by 2
Yin, Z., Xiao, H., McDonald, S., Brusić, V., & Qiu, T. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29301 · Cited by 2
Risk factors for COVID-19 in-hospital mortality in Argentina: A competing risk survival analysis
Calónico, S., Valle, J. C. L. D., & Tella, R. D. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000816 · Cited by 1
Robson, B., & Baek, O. K. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101454 · Cited by 1
Wang, R., Li, Y., Wu, D., Zou, Y., Tang, M., Guan, S., Liu, Y., Jin, Z., Pelinovsky, E. N., Kirillin, M., et al. (2024) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2024.129852 · Cited by 1
Kamara, J., Moses, F., Thekkur, P., Kamara, I. F., Ashubwe-Jalemba, J., Wurie, A. B., Kamara, R. Z., Youkee, D., Samura, S., Bangura, T., et al. (2024) · F1000Research · doi:10.12688/f1000research.149455.1 · Cited by 1
Kayserili, A., & Sançar, B. (2024) · Eurasian Journal of Health Technology Assessment · doi:10.52148/ehta.1520164 · Cited by 3
Razzaghi, A., Afshari, A., Teimouri, H., Daneshi, S., Hushmandi, K., Shahsavarinia, K., & Yazdani, S. (2025) · Russian Open Medical Journal · doi:10.15275/rusomj.2025.0208 · Cited by 1
Best, J., Starkey, T., Chatterjee, A., Fackrell, D. G., Pettit, L., Srihari, N. N., Tween, H., Olsson-Brown, A. C., Cheng, V. W. T., Hughes, D. J., et al. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.05.021 · Cited by 1
Coronavirus Disease Pandemic: A Public Health Perspective
Rao, G. H. R. (2020) · Journal of Medicine and HealthCare · doi:10.47363/jmhc/2020(2)130 · Cited by 1
STUDENTS' PERCEPTIONS ON THEIR READINESS TO STUDY ONLINE: A CASE STUDY OF ONE UNIVERSITY IN SURABAYA
Aminin, Z., & Leliana, A. (2021) · PROJECT (Professional Journal of English Education) · doi:10.22460/project.v4i2.p303-310 · Cited by 1
COVID-19 and Effective Management of Public Transport: Perspective from the Philippines
Lopez, N. S., & Nnadiri, G. U. (2021) · Journal of Mechanical Engineering · doi:10.24191/jmeche.v18i2.14952 · Cited by 1
Spatial Epidemiology: Challenges and Methods in COVID-19 Research
Goel, V., & Emch, M. (2021) · Global perspectives on health geography · doi:10.1007/978-3-030-70179-6_2 · Cited by 1
Challenges of COVID-19 and Tuberculosis - Urgent Need to Tackle the Dual Burden
Dolma, K. G., Mahboob, T., Pereira, M. D. L., Wiart, C., Khandelwal, B., Rahmatullah, M., & Nissapatorn, V. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/413 · Cited by 1
Muley, A., Mitra, S., Bavishi, A., Bhojani, H., Patel, G. M., Nakum, D., Shah, S., Prajapati, P., Abraham, A., Patel, P. S., et al. (2021) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20214520 · Cited by 1
Gupta, S., Rastogi, D., Chauhan, K., & Sharma, S. (2021) · International Conference on System Modeling & Advancement in Research Trends (SMART) · doi:10.1109/smart52563.2021.9676279 · Cited by 1
Sarma, U., & Ghosh, B. (2022) · Scientific Reports · doi:10.1038/s41598-021-03846-z · Cited by 1
Acceptance towards COVID-19 vaccine: A cross-sectional study in the Dominican Republic.
Marte, M. I., Pichardo, E. A., Kandany, V. N., & Castillo, M. M. (2021) · Principles and Practice of Clinical Research Journal · doi:10.21801/ppcrj.2021.74.7 · Cited by 1
Emphasizing visual tools: using R to understand dynamic models of biology and epidemiology
Dayal, V. (2022) · International Journal of Mathematical Education in Science and Technology · doi:10.1080/0020739x.2022.2047811 · Cited by 1
Transformation of substance use disorder treatment services during COVID-19 - A lasting change?
Shapira, B., & Rosca, P. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2070875 · Cited by 1
Statistical Approaches to Infectious Diseases Modelling in Developing Countries: A Case of COVID-19
Gayawan, E., Adekunle, A. I., Pak, A., & Adegboye, O. A. (2022) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003261148-45 · Cited by 1
The COVID-19 Pandemic: Early Ripple Effects in Pediatric Palliative Care
Bustamante, L. M., Okhuysen‐Cawley, R., Downing, J. D., Connor, S. R., Muckaden, M. A., Phillips, M. B., Icaza-Freire, A. P., Garzon, N., Nakashima, Y., Morgan, K., et al. (2022) · Children · doi:10.3390/children9050642 · Cited by 1
Preterm birth and low birth weight
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/1b86da10-en · Cited by 1
Modelación matemática de la propagación del SARS-CoV-2 en la ciudad de Bogotá
Quevedo, D. S., Salas, L., & Serrano, J. D. (2021) · Boletín Epidemiológico Distrital - Bed · doi:10.56085/01238590.169 · Cited by 1
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/3ecfb683-en · Cited by 12
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/36b4eaf9-en · Cited by 1
Schiller, N. R., Usipbekova, K., Hille, K., Dreesman, J. M., Schwarz, K., Reimers, K., Feil, F., & Scheithauer, S. (2023) · Infection Prevention in Practice · doi:10.1016/j.infpip.2023.100294 · Cited by 1
Khan, M., Ahsan, R. N., Iqbal, K., Mobarak, A. M., & Shonchoy, A. (2023) · Applied Economic Perspectives and Policy · doi:10.1002/aepp.13387 · Cited by 1
Severe Malaria with Multiple Complications
Palayukan, A., & Soeheri, N. (2024) · Cermin Dunia Kedokteran · doi:10.55175/cdk.v51i2.865 · Cited by 1
Containment to outbreak tipping points in COVID-19Preprint
Arim, M., Herrera, D., Bermolen, P., Cabana, Á., Fariello, M. I., Lima, M., & Romero, H. (2020) · medRxiv · doi:10.1101/2020.09.14.20194159 · Cited by 1
Jiang, X., Gong, W., Dobreva, Z., Gao, Y., Quaife, M., Fraser, C., & Holmes, C. C. (2021) · medRxiv · doi:10.1101/2021.03.17.21253853 · Cited by 1
Fountain‐Jones, N. M., Yates, L. A., Flies, E. J., Flies, A. S., Carver, S., & Charleston, M. (2021) · medRxiv · doi:10.1101/2021.07.12.21260394 · Cited by 1
Ratio of people aged 15-64 to people aged over 65 years, 2020 and 2050
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/9747df29-en · Cited by 1
Ma, Z., Chen, Q., He, J., Feinstein, M. J., Mimiaga, M. J., & Jiang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1483723/v1 · Cited by 1
Infants exclusively breastfed – first 6 months of life
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/e9b15b52-en · Cited by 1
U.S. state-level COVID-19 transmission insights from a mechanistic mobility-incidence modelPreprint
Thommes, E. W., Mohammadi, Z., Flynn-Primrose, D., Smook, S., Gomez, G. B., Chaves, S. S., Coudeville, L., van Aalst, R., Mahé, C., & Cojocaru, M. G. (2022) · medRxiv · doi:10.1101/2022.06.21.22276712 · Cited by 1
Employment Loss in Informal Settlements during the Covid-19 Pandemic: Evidence from ChilePreprint
Gil, D., Domínguez, P., Undurraga, E. A., & Valenzuela, E. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4013084 · Cited by 1
The psychological mechanism of internet information processing for post-treatment evaluationPreprint
Vuong, Q., Le, T.-T., La, V., & Nguyen, M. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/n29cb · Cited by 1
Więcek, W., Johnston, D., Dulka, T., Toomey, D., & Lewis, E. (2023) · medRxiv · doi:10.1101/2023.06.16.23291442 · Cited by 2
Ichihara, M. Y., Costa, L. C. C. D., Fiaccone, R. L., de Medeiros, A. G. P., Bellido, J. G., Souza, R., Rocha, C. I. A., dos Anjos, A. F., Sebastião, M., Pimenta, D. N., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4598002 · Cited by 1
Borba, M. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2023.tde-05022024-163230 · Cited by 4
Lai, Y., Li, Y., Wu, B., Tian, Y., Zhang, X., Shi, B., Wu, Q., & Jiao, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3984478/v1 · Cited by 1
Inference of epidemic dynamics in the COVID-19 era and beyondPreprint
Cori, A., & Kucharski, A. J. (2024) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/mg497 · Cited by 2
Precognition of Known And Unknown Biothreats: A Risk-Based Approach
Lapitan, R. L. (2024) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2023.0169 · Cited by 1
The cost of myopic pandemic responsePreprint
Nowak, S. A., de Lima, P. N., & Vardavas, R. (2024) · medRxiv · doi:10.1101/2024.02.19.24303020 · Cited by 1
The importance of timing of a population level intervention on COVID-19 mortalityPreprint
Johnston, J. S., Johnston, E. S., & Johnston, S. L. (2020) · medRxiv · doi:10.1101/2020.04.19.20071845
Surges in COVID-19 are led by lax government interventions in initial outbreaksPreprint
Yuan, H., Wu, L. C., & Wang, D. (2020) · medRxiv · doi:10.1101/2020.07.17.20156604
Clustering of age standardised COVID-19 infection fatality ratios and death trajectoriesPreprint
Kelly, T., Humphrey, G. B., Miller, C. L., Bowden, J. A., Dono, J., & Phillips, P. A. (2020) · medRxiv · doi:10.1101/2020.08.11.20172478
Það sem ég tala um þegar ég tala um COVID-19
Aspelund, T. (2020) · Læknablaðið · doi:10.17992/lbl.2020.09.594
Abedin, S., Khan, A. R., & Khan, S. (2020) · Research Square · doi:10.21203/rs.3.rs-75767/v1
Some aspects of the process development forecast the spread of COVID 19 infection.Preprint
Kotel’nikov, V. I., Krasilnikov, M., Ryazanova, E., & Chysyma, R. (2020) · Research Square · doi:10.21203/rs.3.rs-110358/v1
Amaya, H., Enciso, J., Meizner, D., Pentland, A., & Noriega-Campero, A. (2021) · medRxiv · doi:10.1101/2021.01.18.21250034
Montes, F., Meisel, J. D., Lemoine, P. D., Higuera-Mendieta, D. R., Useche, A. F., Baquero, S., Quintero, J., Martínez, D. A., Idrobo, L. I., Jaramillo, A. M., et al. (2020) · Revista de Ingeniería · doi:10.16924/revinge.50.3
The Impact of COVID-19 Pandemic on Critical Care Systems in Low- and Middle-Income Countries
Williams, G. F., Kusi‐Appiah, E., & Papathanassoglou, E. D. E. (2021) · Connect The World of Critical Care Nursing · doi:10.1891/wfccn-d-21-00004
Hassan, S., Salman, Μ. D., & Mustafa, T. (2020) · Research Square · doi:10.21203/rs.3.rs-77989/v1
Effect of COVİD-19 Pandemic on General Surgery Practice and Resident EducationPreprint
Erol, T., Mahmudzada, K., Kırımtay, B., Doğu, D., Oruç, M., & Yorgancı, K. (2021) · Research Square · doi:10.21203/rs.3.rs-593813/v1
Young, J., He, E. M., Boone, D., Luehr, J., Tasnim, K., Turner, M., Ambatipudi, M., Gonzalez, P. C., Mooney, D. J., & Koh, E. G. L. (2021) · doi:10.14293/s2199-1006.1.sor-.ppaahgk.v1
Omata, K., & Mitsuya, H. (2021) · Research Square · doi:10.21203/rs.3.rs-709496/v1
Costa, L. F., Souza, R. B., de Oliveira, A. M. M., & Limongi, J. E. (2021) · doi:10.20517/ohir.2021.05
The Economic Impact of COVID-19 on Various Areas of Health
Goudarzi, R., & Kalavani, K. (2021) · Quarterly Journal of Management Strategies in Health System · doi:10.18502/mshsj.v6i2.7174
Desafíos de la pandemia de COVID-19
Villaverde, J. O. A. (2021) · Anales de la Facultad de Medicina · doi:10.15381/anales.v82i1.20818
Hayran, O., & Yiğit, P. (2021) · JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH · doi:10.34084/bshr.985424
Ertekin, A. (2021) · Marmara Üniversitesi Siyasal Bilimler Dergisi · doi:10.14782/marmarasbd.913427
Jain, S., Tiwari, A., Bannur, N., Deva, A., Shingi, S., Shah, V., Kulkarni, M., Deka, N., Ramaswami, K., Khare, V., et al. (2021) · medRxiv · doi:10.1101/2021.11.01.21260020
Kaushik, R., Nikita, N., Rishabh, Lugani, Y., & Lata, S. (2021) · Research Square · doi:10.21203/rs.3.rs-1098955/v1
[Clinical significance of positive sputum culture for filamentous fungi].
Shi, X., Liu, Z., Xu, Y., & Wang, A. (2010) · PubMed
Magnitude, global variation, and temporal development of the COVID-19 infection fatality burdenPreprint
Bohk-Ewald, C., Acosta, E., Riffe, T., Dudel, C., & Myrskylä, M. (2021) · medRxiv · doi:10.1101/2021.12.17.21267986
Magnitude, global variation, and temporal development of the COVID-19 infection fatality burden
Bohk-Ewald, C., Acosta, E., Riffe, T., Dudel, C., & Myrskylä, M. (2021) · doi:10.4054/mpidr-wp-2021-024
Tesfaye, A., Washo, A., Muche, T., Asefa, B., & Kanno, G. G. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3951698
Zhu, Q., Gao, J., Gu, J., Shen, L. H., Liu, J., Song, Y., Gong, X., Chen, Y., Liao, J., He, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3936498
Economic Effects of Covid-19 on Tourism Sector in Pakistan
Akmal, A., Laeeque, B., & Mehar, B. (2021) · Journal of Business & Tourism · doi:10.34260/jbt.v7i1.215
Tamayo-Legorreta, E. M., & Moreno-Vazquez, E. (2021) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2021.09.00330
Occurrence of Covid-19 in different communities in Kolkata
Mukhopadhyay, J., Chatterjee, A., Mallik, D., & Chatterjee, C. (2021) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v12i8.36907
A systematic review of the neglect of non-COVID patients amidst COVID pandemic
Mishra, P., Nath, A., Sharma, S., & Kumar, A. (2021) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1398
Increased Knowledge About COVID-19 Vaccination of Non-Medical College Students in Surabaya
Setyanisa, A. R., Purwati, D. D., Rizal, M. M., & Indiastuti, D. N. (2021) · International Journal of Research Publications · doi:10.47119/ijrp100921120222669
SAÚDE NA FRONTEIRA EM TEMPOS DE PANDEMIA: ANÁLISE DA MÍDIA EM FOZ DO IGUAÇU-PR
Fontana, B., & Cividini, F. R. (2022) · Contribuciones a las Ciencias Sociales · doi:10.51896/ccs/fsuf1625
Developmental Agenda and the Global Pandemic
Afsharinia, B., Gurtoo, A., & Shaw, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-5074-1_2
Prevalence of overweight among children under age 5, latest year available
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/26591c28-en
Mental health beds per 100 000 population, 2016 or latest year available
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/f1bdf043-en
Colon cancer five-year net survival, patients diagnosed during 2000-04 and 2010-14
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/fe9135ed-en
Proportions of all cause deaths, 2016
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/6718a325-en
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/bdca639e-en
OECD, & World Health Organization (2020) · Health at a glance. Asia/Pacific · doi:10.1787/12a2742f-en · Cited by 10
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/adc09b14-en
Estimate of the burden of disease caused by tuberculosis, 2018
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/aa0d8d52-en
Injuries, age-specific mortality rates, 2016
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/82f6c4f0-en
Under age 5 mortality rates, 2000-18 (or latest year available)
(2020) · Health at a glance. Asia/Pacific · doi:10.1787/ea558d4d-en
Metadata
- Authors
- Walker, P. G. T., Whittaker, C., Watson, O. J., Baguelin, M., Winskill, P., Hamlet, A., Djafaara, B. A., Cucunubá, Z., Olivera Mesa, D., Green, W., Thompson, H., Nayagam, S., Ainslie, K. E. C., Bhatia, S., Bhatt, S., Boonyasiri, A., Boyd, O., Brazeau, N. F., Cattarino, L., Cuomo-Dannenburg, G., Dighe, A., Donnelly, C. A., Dorigatti, I., van Elsland, S. L., FitzJohn, R., Fu, H., Gaythorpe, K. A. M., Geidelberg, L., Grassly, N., Haw, D., Hayes, S., Hinsley, W., Imai, N., Jorgensen, D., Knock, E., Laydon, D., Mishra, S., Nedjati-Gilani, G., Okell, L. C., Unwin, H. J., Verity, R., Vollmer, M., Walters, C. E., Wang, H., Wang, Y., Xi, X., Lalloo, D. G., Ferguson, N. M., & Ghani, A. C.
- Affiliations
- Imperial College London (GB)
- Brown University (US)
- London School of Hygiene & Tropical Medicine (GB)
- MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
- University of Oxford (GB)
- Liverpool School of Tropical Medicine (GB)
- Corresponding author
- Walker, Patrick G. T.
- Whittaker, Charles
- Watson, Oliver J.
- Ferguson, Neil M.
- Ghani, Azra C.
- ORCID
- Walker, Patrick G. T.
- Whittaker, Charles
- Watson, Oliver J.
- Baguelin, Marc
- Winskill, Peter
- Hamlet, Arran
- Djafaara, Bimandra A.
- Cucunubá, Zulma
- Olivera Mesa, Daniela
- Green, Will
- Thompson, Hayley
- Nayagam, Shevanthi
- Ainslie, Kylie E. C.
- Bhatia, Sangeeta
- Bhatt, Samir
- Boonyasiri, Adhiratha
- Boyd, Olivia
- Brazeau, Nicholas F.
- Cattarino, Lorenzo
- Cuomo-Dannenburg, Gina
- Dighe, Amy
- Donnelly, Christl A.
- Dorigatti, Ilaria
- FitzJohn, Rich
- Fu, Han
- Gaythorpe, Katy A. M.
- Geidelberg, Lily
- Grassly, Nicholas
- Haw, David
- Hayes, Sarah
- Hinsley, Wes
- Imai, Natsuko
- Jorgensen, David
- Knock, Edward
- Laydon, Daniel
- Mishra, Swapnil
- Nedjati-Gilani, Gemma
- Okell, Lucy C.
- Unwin, H. Juliette
- Verity, Robert
- Vollmer, Michaela
- Walters, Caroline E.
- Wang, Haowei
- Wang, Yuanrong
- Xi, Xiaoyue
- Lalloo, David G.
- Ferguson, Neil M.
- Ghani, Azra C.
- Venue
- Science
- Published
- 2020-07-24
- Volume
- 369
- Issue
- 6502
- Pages
- 413-422
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7292504
- OpenAlex
- W3035706118
- Semantic Scholar
- 4f2e1c57a649d91d0b3322bc76c3ae8cdebc08a3
- Cited by
- 993
- References
- 54
- Citations by year
- 2026: 18 · 2025: 42 · 2024: 69 · 2023: 122 · 2022: 215 · 2021: 281 · 2020: 245
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Wellcome (221350/Z/20/Z)
- Medical Research Council
- National Institute for Health Research
- Community Jameel
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, low- and middle-income countries, mitigation measures, suppression strategy, health system capacity, excess mortality, intergenerational interaction, disease severity, contact patterns, age structure, quality of care, pandemic response
- MeSH terms
- COVID-19, Developing Countries, Humans, Patient Acceptance of Health Care, Pneumonia, Viral, Poverty, Public Health, Global Health, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.